Transcriptional activation of the cdc2 gene is associated with Fas-induced apoptosis of human hematopoietic cells

J Biol Chem. 1996 Nov 8;271(45):28469-77. doi: 10.1074/jbc.271.45.28469.

Abstract

Apoptosis has recently been hypothesized to be the result of aberrant cell cycle control. In this study, we have investigated the role of cell cycle-regulatory elements in Fas-induced apoptosis of hematopoietic cells. When HL-60 cells were treated with anti-Fas antibody, rapid activation of growth-associated histone H1 kinase was observed without any change in cell cycle distribution. This was accompanied by the increase in cdc2 mRNA expression and Cdc2 kinase activity. Up-regulation of cdc2 mRNA was similarly induced in BCL-2-overexpressing HL-60 subline by anti-Fas treatment independently of the appearance of apoptotic phenotypes. Fas-induced apoptosis was completely inhibited by butyrolactone I, a specific inhibitor of Cdc2 kinase. Moreover, the same phenomenon was observed during Fas-induced but not spontaneous apoptosis of postmitotic granulocytes. Finally, we have found that "Fas-responsive element" was located between nucleotides -730 and -552 of the cdc2 promoter and was responsive for transcriptional activation of the cdc2 gene during Fas-induced apoptosis. These results indicate that aberrant activation of Cdc2 is associated with Fas-induced apoptosis of hematopoietic cells, and that the mechanism of cdc2 transcription during Fas-induced apoptosis is different from that in normal cell cycle control.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Blotting, Northern
  • CDC2 Protein Kinase / genetics*
  • Cyclin-Dependent Kinases / metabolism
  • Gene Expression Regulation, Enzymologic
  • Granulocytes / metabolism
  • HL-60 Cells
  • Hematopoietic Stem Cells / cytology*
  • Hematopoietic Stem Cells / drug effects
  • Humans
  • Kinetics
  • Maturation-Promoting Factor / metabolism
  • RNA, Messenger / metabolism
  • Transcription, Genetic*
  • Up-Regulation
  • fas Receptor / pharmacology*

Substances

  • RNA, Messenger
  • fas Receptor
  • CDC2 Protein Kinase
  • Cyclin-Dependent Kinases
  • Maturation-Promoting Factor